CDK7 and cancer: The TFIIH complex subunit cyclin-dependent kinase 7 (CDK7), which controls the cell cycle and initiates transcription by Pol II, has emerged as a brand-new target for treating cancer (Larochelle et al., 2012; Suski et al., 2021).